top of page

Biotech as a Service
Accelerate your early Drug Development

aclrt.bio

An integrated development engine for early oncology and immunology assets

How to move promising assets to Proof of Concept with speed, rigor, and
must-have capacities?

 

Our model is designed for organizations and teams that need senior, integrated execution power without building a full in‑house development organization. Whether you are launching a new biotech, scaling a portfolio company, or translating academic innovation into development, we plug in as a single, accountable development engine aligned to your goals.

Founders & Biotech Teams

Laboratoire

You have a strong asset, but not yet a full development organization.

​

We help you:

  • Fill senior execution gaps

  • Move faster without over‑building

  • Stay focused on value‑defining milestones

  • Operate with pharma‑grade discipline from day one

Discuss your program

Investors (VCs)

Expérience en boîte de Petri

Execution risk is one of the biggest threats to value creation.

​

We support investors by:

  • De‑risking development strategies

  • Supporting technical diligence

  • Strengthening portfolio company execution

  • Bridging gaps between financing and delivery

​

Portfolio support discussion

Academic Spin‑outs

Équipement de test de laboratoire

Translating science into development is a major step.

​

We help spin‑outs:

  • Build development‑ready programs

  • Structure early regulatory and CMC decisions

  • Prepare assets for funding and partnerships

​

​

Discuss spin‑out support

Pharma & Partners

Scène de travail en laboratoire

We support partnered assets through:

​

  • Embedded development leadership

  • Defined‑scope execution support

  • Independent, execution‑focused oversight

​

​​

​

​

Partner with us
bottom of page